ElectroCore
$9.99
40
+$1.01+11.25% 今天
统计数据
当日最高
10.2
当日最低
9.25
52周最高
10.2
52周最低
5.02
成交量
204,369
平均成交量
21,103
市值
39M
市盈率
-
股息收益率
-
股息
-
即将到来
收益
14Nov预期
预期每股收益
-0.305
实际每股收益
N/A
人们还关注
此列表基于关注ECOR的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Axonics
AXNX
市值3.54B
LivaNova
LIVN
市值2.74B
Inspire Medical Systems
INSP
市值5.36B
Neogen
NEOG
市值3.74B
Boston Scientific
BSX
市值120.45B
Abbvie
ABBV
市值346.75B
Medtronic
MDT
市值113.61B
Smith & Nephew
SNN
市值13.45B
Stryker
SYK
市值137.35B
关于
Health Technology
Medical Specialties
Manufacturing
Electromedical and Electrotherapeutic Apparatus Manufacturing
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Show more...
首席执行官
员工
68
国家
US
ISIN
US28531P1030